619 related articles for article (PubMed ID: 34470691)
21. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
Pelton RW; Peterson EA; Patel BC; Davis K
Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
[TBL] [Abstract][Full Text] [Related]
22. Rhino-orbito-cerebral mucormycosis in an immunocompetent patient: case report and review of literature.
Shatriah I; Mohd-Amin N; Tuan-Jaafar TN; Khanna RK; Yunus R; Madhavan M
Middle East Afr J Ophthalmol; 2012; 19(2):258-61. PubMed ID: 22623872
[TBL] [Abstract][Full Text] [Related]
23. Rhino-orbito-cerebral mucormycosis: five cases.
Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
[TBL] [Abstract][Full Text] [Related]
24. Chronic orbital and calvarial fungal infection with Apophysomyces variabilis in an immunocompetent patient.
Wolkow N; Jakobiec FA; Stagner AM; Cunnane ME; Piantadosi AL; Basgoz N; Lefebvre D
Surv Ophthalmol; 2017; 62(1):70-82. PubMed ID: 27256687
[TBL] [Abstract][Full Text] [Related]
25. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
[TBL] [Abstract][Full Text] [Related]
26. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
[TBL] [Abstract][Full Text] [Related]
27. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
[TBL] [Abstract][Full Text] [Related]
28. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases.
Santos Gorjón P; Blanco Pérez P; Batuecas Caletrío A; Muñoz Herrera AM; Sánchez González F; de la Fuente Cañibano R
Acta Otorrinolaringol Esp; 2010; 61(1):48-53. PubMed ID: 20004878
[TBL] [Abstract][Full Text] [Related]
29. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
32. Increased Incidence of Rhino-Orbital-Cerebral Mucormycosis After Colorado Flooding.
Davies BW; Smith JM; Hink EM; Durairaj VD
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S148-S151. PubMed ID: 25794032
[TBL] [Abstract][Full Text] [Related]
33. Management of bilateral rhino-orbital cerebral mucormycosis.
Lam SC; Yuen HKL
Hong Kong Med J; 2019 Oct; 25(5):408-409. PubMed ID: 31761754
[No Abstract] [Full Text] [Related]
34. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
35. Rhino-orbital mucormycosis due to Apophysomyces ossiformis in a patient with diabetes mellitus: a case report.
Martínez-Herrera E; Frías-De-León MG; Julián-Castrejón A; Cruz-Benítez L; Xicohtencatl-Cortes J; Hernández-Castro R
BMC Infect Dis; 2020 Aug; 20(1):614. PubMed ID: 32811466
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
[TBL] [Abstract][Full Text] [Related]
37. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
38. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report.
Prasad S; Gaur A; Mehta A; Kaushal N
BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
40. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
